zopolrestat has been researched along with Fatty Liver, Nonalcoholic in 2 studies
zopolrestat: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T | 1 |
| Shi, D | 1 |
| Chen, J | 1 |
| Yang, Y | 1 |
| Qiu, M | 1 |
| Wang, W | 1 |
| Qiu, L | 2 |
| Lin, J | 1 |
| Xu, F | 1 |
| Gao, Y | 1 |
| Zhang, C | 1 |
| Liu, Y | 1 |
| Luo, Y | 1 |
| Yang, JY | 1 |
2 other studies available for zopolrestat and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Inhibition of aldose reductase ameliorates diet-induced nonalcoholic steatohepatitis in mice via modulating the phosphorylation of hepatic peroxisome proliferator-activated receptor α.
Topics: Aldehyde Reductase; Animals; Benzothiazoles; Diet; Disease Models, Animal; Enzyme Activation; Enzyme | 2015 |
Inhibition of aldose reductase activates hepatic peroxisome proliferator-activated receptor-α and ameliorates hepatosteatosis in diabetic db/db mice.
Topics: Aldehyde Reductase; Animals; Benzothiazoles; Diabetes Mellitus; Diabetes Mellitus, Type 2; Enzyme In | 2012 |